Merger Alert: Tryp Therapeutics Signs With Australian Drug Delivery Innovator, Details Here
Canadian psychedelics biotech Tryp Therapeutics Inc. has entered into an agreement with Australian publicly-trading drug vehicle developer Exopharm Ltd. for the acquisition of 100% of Tryp’s issued and outstanding common shares.
